Fact-Finding Mission Fact-Finding Mission to Chongqing, Dalian/Liaoyang & Beijing 24.06.2024–28.06.2024 Китай
News 17.04.2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 23.10.2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News 27.03.2024 TissueLabs begins biofabrication activities in Bellinzona TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh ...
News 13.12.2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
News 12.03.2024 Nanoflex Robotics installs first robot for vascular interventions in the USA Nanoflex Robotics has installed its first remote-controlled robotics system for neurovascular procedures in the USA. The magnetically controlled ...
News 23.02.2024 UZH on the case of a cause of dementia A team from the University of Zurich (UZH) has developed an innovative cell culture model for nerve cells. This shows that there is a correlation...
News 26.01.2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
News 19.02.2024 Solita opens new office in Zurich under its Intellishore brand Solita, the Finnish data analysis and strategic consulting firm, is opening an office in Zurich under its Danish brand Intellishore. Intellishore...
News 14.02.2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 18.10.2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 06.02.2024 QUMEA secures investment of 9 million Swiss francs QUMEA has raised funding of 9 million Swiss francs as part of an oversubscribed Series A financing round. With this fresh capital, the digital he...
News 22.01.2024 DISCO Pharmaceuticals secures seed funding of 20 million euros DISCO Pharmaceuticals has secured seed funding of 20 million euros and officially launched the business. The team was the first to develop a meth...
News 10.01.2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 04.01.2024 Lucerne University of Applied Sciences and Arts to teach nursing at degree level Lucerne University of Applied Sciences and Arts will begin teaching degree-level nursing from the 2024 fall semester. It is also expanding its pr...
News 22.12.2023 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
News 07.06.2023 Genedata expanding its user network The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site in South K...
News 06.10.2022 Biopôle expands further with the construction of three new buildings Biopôle has announced that Edmond de Rothschild Real Estate SICAV will be investing in the construction of three new buildings on the campus in E...